Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 15 drugs
Mavorixafor is a CXC chemokine receptor 4 (CXCR4) antagonist. It was first approved by the FDA on April 30, 2024, for the treatment of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, a genetic immunodeficiency disorder characterized by a reduced number of mature neutrophils and lymphocytes. WHIM syndrome is caused by...
Approved
Investigational
Matched Description: … approved by the FDA on April 30, 2024, for the treatment of warts, hypogammaglobulinemia, infections, and ... syndrome, a genetic immunodeficiency disorder characterized by a reduced number of mature neutrophils and ... human immunodeficiency virus (HIV), Waldenstrom’s macroglobulinemia (WM), B-cell non-Hodgkin lymphoma, and
Matched Categories: … MATE 1 Inhibitors …
Zinc oxide is an inorganic compound used in a number of manufacturing processes. It can be found in rubbers, plastics, ceramics, glass, cement, lubricants, paints, ointments, adhesives, sealants, pigments, foods, batteries, ferrites, fire retardants, and first-aid tapes. It occurs naturally as the mineral zincite, but most zinc oxide is produced...
Approved
Matched Description: … It is also widely used to treat a variety of other skin conditions, in products such as baby powder and ... barrier creams to treat diaper rashes, calamine cream, anti-dandruff shampoos, and antiseptic ointments ... lubricants, paints, ointments, adhesives, sealants, pigments, foods, batteries, ferrites, fire retardants, and
Matched Mixtures name: … Clinique Cx Protective Base SPF 40 ... Clinique Cx Protective Base SPF 40 ... ZOLBENE CREMA TOPICA (CALAMINA 5% + OXIDO DE ZINC 5% + ALCOHOL BENCILICO 1%) …
Matched Categories: … Basic Powders and Demulcents ... Basic Ointments and Protectants ... Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use …
Matched Products: … 5-IN-1 Tinted Face Sunscreen - Fair ... 5-IN-1 Tinted Face Sunscreen - Light ... 5-IN-1 Tinted Face Sunscreen - Medium …
Andusomeran is a COVID-19 mRNA vaccine developed for use during the 2023-2024 season.[L40074,L48832,L48837] It is similar to previous mRNA vaccines developed by Moderna (e.g. elasomeran, imelasomeran), but is designed to be effective against the Omicron XBB.1.5 subvariant.
Approved
Matched Synonyms: … CX-038839 Omicron (XBB.1.5) ... COVID-19 mRNA vaccine, monovalent (XBB.1.5 Variant) …
Matched Description: … [elasomeran], [imelasomeran]), but is designed to be effective against the Omicron XBB.1.5 subvariant …
Matched Products: … Spikevax XbB.1.5
Titanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium. It is used as a pigment under the names titanium white, Pigment White 6 (PW6), or CI 77891. It is typically extracted from ilmenite, rutile and anatase.
Approved
Matched Description: … It is typically extracted from ilmenite, rutile and anatase. …
Matched Mixtures name: … Clinique Cx Protective Base SPF 40 ... Camera Ready 5 In 1 Beauty Balm SPF 35 ... Clinique Cx Protective Base SPF 40 …
Matched Categories: … Astringents and Deodorants …
Matched Products: … Cx Daily Eye Protector SPF 15 ... bareMinerals 5-in-1 BB Advanced Performance Eyeshadow Broad Spectrum SPF 15 Soft Shell ... bareMinerals 5-in-1 BB Advanced Performance Eyeshadow Broad Spectrum SPF 15 Soft Linen …
Octinoxate is a cinnamate ester and common ingredient in sunscreen and other skin care products to minimize DNA photodamage. It was originally developed in 1950's as an organic UV-B filter that absorbs UV-B rays from sun. It is often combined with nanoparticles or other water-resistant liposomes in formulations to increase...
Approved
Investigational
Matched Description: … Octinoxate is a cinnamate ester and common ingredient in sunscreen and other skin care products to minimize ... Its use in pharmaceutical and cosmetic formulations is approved by FDA. ... nanoparticles or other water-resistant liposomes in formulations to increase the localization at the epidermis and
Matched Mixtures name: … Clinique Cx Protective Base SPF 40 ... Clinique Cx Protective Base SPF 40 ... Eco Soul Skin Wear Foundation C 1.5
Matched Categories: … Emollients and Protectives …
Matched Products: … GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 ... Revitalizing Concealer - Stk 5% ... Revitalizing Liquid Make-UP - 5% …
CX-2009 is under investigation in clinical trial NCT03149549 (PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors).
Investigational
Matched Synonyms: … Anti-cd166 probody-drug conjugate cx-2009 …
Matched Name: … CX-2009 …
Matched Description: … and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors). ... CX-2009 is under investigation in clinical trial NCT03149549 (PROCLAIM-CX-2009: A Trial to Find Safe …
Pacmilimab is under investigation in clinical trial NCT04596150 (Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer).
Investigational
Matched Synonyms: … IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH-LIGAND 1) (HUMAN MONOCLONAL CX-072 .GAMMA.4-CHAIN ... Cx-072 probody ... ), DISULFIDE WITH PRODOMAIN PROTEIN (SYNTHETIC MASKING MOIETY AND CLEAVABLE MOIETY PROTEASE SUBSTRATE-CONTAINING …
Matched Description: … Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer). ... Pacmilimab is under investigation in clinical trial NCT04596150 (Study to Evaluate the Safety and Antitumor …
Investigational
Matched Synonyms: … CXC chemokine receptor types 1 and 2 inhibitor RP72 ... 72 amino acid proprietary recombinant protein antagonist for the CXCR1 and CXCR2 receptors of interleukin …
Investigational
Matched Synonyms: … Fc-fusion protein comprised of an anti-CXCR4 i-body tethered at its C-terminus to constant domains 2 and
Cx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and toes, contraction of the mouth membranes and narrowing of the oesophagus. It is developed by Cellerix and is in phase I of clinical trials.
Investigational
Matched Description: … It is developed by Cellerix and is in phase I of clinical trials. ... toes, contraction of the mouth membranes and narrowing of the oesophagus. ... bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and
CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous MAO-A inhibitors of this class.
Investigational
Matched Description: … dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and
Investigational
Matched Iupac: … 6-(piperidine-1-carbonyl)quinoxaline …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).
Investigational
CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure).
Investigational
Matched Iupac: … N-hydroxy-2-methanesulfonylbenzene-1-sulfonamide …
Matched Description: … CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics …
CXD101 is under investigation in clinical trial NCT03873025 (A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-cell Lymphoma).
Investigational
Matched Iupac: … N-(2-aminophenyl)-4-{1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin-4-yl}benzamide …
Displaying all 15 drugs